Skip to main content
OpenTrials
Completed

NCT Number: NCT06353074

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage

This study is aimed to show effectiveness of a new suture technique to stop postpartum uterine bleeding due to uterine atony.

Completed

Looking for future studies?

Notify Me

Key information

About this study

A retrospective study of all women received Acar's uterine compressive atony suture between January 2021-November 2023 at a single tertiary hospital with approximately 4000 deliveries per year, was performed. The local protocol for PPH due to uterine atony is uterine manual compression, 20 IU of intravenous oxytocin in 500 cc of normal saline at 500 cc/h; 800 µg of misoprostol inserted per rectal. If additional treatment is needed, carbetocin 100mcg in 100 cc of normal saline or tranexamic acid in different posologies are used.

If uterine atony persists, intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery. When uterine compressive suture was performed, original Acar's atony suture was applied.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women without systemic disease

Exclusion criteria

  • cardiac disease
  • rheumatological disease

Treatment and study plan

Primary outcomes

  1. Postpartum hysterectomy and/or intensive care unit need ratio

    Time frame: Since first operation to discharge from hospital assessed up to 5 days

    The need for hysterectomy or massive transfusion because of unstoppable and mortal bleeding

Sponsors and collaborators

Lead sponsor

Necmettin Erbakan University

Other

Registry information

Official study title

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Atony

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Apr 8, 2024
Registry last updated
Apr 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.